Abstract

Jaundice is the most common finding during neonatal period. It is observed during the 1st week of life in approximately 60% of term infant and 80% of preterm infants. Level of serum bilirubin is not raised that much so as to cause fatal brain damage. It is the most common disease during neonatal period occurring mostly due to increased hemolysis, decreased hepatic clearance, enterohepatic circulation, immaturity, blood group incompatibility and infections. Its management includes 1] Phototherepy 2] Exchange transfusion are two major effective therapeutic modalities available today. Additional options include Pharmacotherapy in the form of phenobarbital and high dose intravenous immunoglobulin.

Highlights

  • Jaundice is an important problem in the 1st week of life

  • 60% of terms new born become visibly jaundiced in the 1st week of life

  • 5-10% of them have clinically significant jaundice mandating the use of phototherapy or other therapeutic options

Read more

Summary

Introduction

Jaundice is an important problem in the 1st week of life. It is the yellow discolouration of the skin and sclera due to raised serum bilirubin. Under normal circumstance the level of indirect bilirubin in umbilical cord serum is 1-3 mg/dl and rises at a rate of

Classification based on the time of onset
Classification based on conjugation of bilirubin
Findings
Clinical Approach
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.